Legal Representation
Attorney
Joyce M. Ferraro
USPTO Deadlines
Next Deadline
173 days remaining
NOA E-Mailed - SOU Required
Due Date
January 01, 2026
Extension Available
Until July 01, 2026
Application History
25 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 1, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| May 6, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| May 6, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Apr 30, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Apr 3, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 25, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 25, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Feb 25, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Dec 12, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Dec 12, 2024 | GNFR | O | FINAL REFUSAL E-MAILED |
| Dec 12, 2024 | CNFR | R | FINAL REFUSAL WRITTEN |
| Nov 5, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Nov 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Aug 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Aug 9, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 9, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Aug 7, 2024 | DOCK | D | ASSIGNED TO EXAMINER |
| Jul 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 1, 2024 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Jul 1, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Jul 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jun 17, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Jun 17, 2024 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Synthetic peptide pharmaceutical preparations for inducing and augmenting bone formation and repair; synthetic growth-factor peptides applied to orthopedic medical devices and materials for use with invasive and non-invasive medical procedures, namely, synthetic growth-factor peptide pharmaceutical preparations for inducing and augmenting bone formation and repair
Classification
International Classes
005